Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

G Riou

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Physiology

Chemicals & Drugs

Genes & Molecular Sequences

Disorders

Anatomy

Cultured Tumor Cells

Living Beings

Trypanosoma cruzi

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
15
Bénard, Jean
12
Riou, Jean-François
6
Duvillard, Pierre
6
Spielmann, Marc
5
Terrier-Lacombe, Marie-José
5
Mathieu, Marie-Christine
5
Hartmann, Olivier
5
Lê, Monique
5
Lemerle, Jean
4
Moll, Ute
4
prost, sandrine
3
Lhomme, Catherine
2
Le Bihan, ML
2
Terrier, Philippe
2
Travagli, Jean-Paul

Sign-in to see all Coauthors

Publications

TOP 3
Padlewska K; Ramoz N; Cassonnet P; Riou G; Barrois M; Majewski S; Croissant O; Jablonska S; Orth G
Mutation and abnormal expression of the p53 gene in the viral skin carcinogenesis of epidermodysplasia verruciformis.
Riou G; Mathieu M C; Barrois M; Le Bihan M L; Ahomadegbe J C; Bénard J; Lê M G
c-erbB-2 (HER-2/neu) gene amplification is a better indicator of poor prognosis than protein over-expression in operable breast-cancer patients.
Ahomadegbe J C; Tourpin S; Kaghad M; Zelek L; Vayssade M; Mathieu M C; Rochard F; Spielmann M; Tursz T; Caput D; Riou G; Bénard J
Loss of heterozygosity, allele silencing and decreased expression of p73 gene in breast cancers: prevalence of alterations in inflammatory breast cancers.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of G Riou (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2001: Padlewska K; Ramoz N; Cassonnet P; Riou G; Barrois M; Majewski S; Croissant O; Jablonska S; Orth G
Mutation and abnormal expression of the p53 gene in the viral skin carcinogenesis of epidermodysplasia verruciformis.
The Journal of investigative dermatology 2001;117(4):935-42.
2001: Riou G; Mathieu M C; Barrois M; Le Bihan M L; Ahomadegbe J C; Bénard J; Lê M G
c-erbB-2 (HER-2/neu) gene amplification is a better indicator of poor prognosis than protein over-expression in operable breast-cancer patients.
International journal of cancer. Journal international du cancer 2001;95(4):266-70.
2000: Ahomadegbe J C; Tourpin S; Kaghad M; Zelek L; Vayssade M; Mathieu M C; Rochard F; Spielmann M; Tursz T; Caput D; Riou G; Bénard J
Loss of heterozygosity, allele silencing and decreased expression of p73 gene in breast cancers: prevalence of alterations in inflammatory breast cancers.
Oncogene 2000;19(47):5413-8.
1999: Lê M G; Mathieu M C; Douc-Rasy S; Le Bihan M L; Adb El All H; Spielmann M; Riou G
c-myc, p53 and bcl-2, apoptosis-related genes in infiltrating breast carcinomas: evidence of a link between bcl-2 protein over-expression and a lower risk of metastasis and death in operable patients.
International journal of cancer. Journal international du cancer 1999;84(6):562-7.
1998: Fogel S; Riou G
The early HPV16 proteins can regulate mRNA levels of cell cycle genes in human cervical carcinoma cells by p53-independent mechanisms.
Virology 1998;244(1):97-107.
1996: Fajac A; Da Silva J; Ahomadegbe J C; Rateau J G; Bernaudin J F; Riou G; Bénard J
Cisplatin-induced apoptosis and p53 gene status in a cisplatin-resistant human ovarian carcinoma cell line.
International journal of cancer. Journal international du cancer 1996;68(1):67-74.
1996: Vassal G; Terrier-Lacombe M J; Lellouch-Tubiana A; Valery C A; Sainte-Rose C; Morizet J; Ardouin P; Riou G; Kalifa C; Gouyette A
Tumorigenicity of cerebellar primitive neuro-ectodermal tumors in athymic mice correlates with poor prognosis in children.
International journal of cancer. Journal international du cancer 1996;69(2):146-51.
1996: Fogel S; Ahomadegbe J C; Barrois M; Le Bihan M L; Douc-Rasy S; Duvillard P; Armand J P; Riou G
[High incidence of p53 mutations in primary and metastatic head and neck tumors. Frequent protein overexpression in normal epithelium]
Bulletin du cancer 1996;83(3):227-33.
1996: Douc-Rasy S; Barrois M; Fogel S; Ahomadegbe J C; Stéhelin D; Coll J; Riou G
High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19.
Oncogene 1996;12(2):423-30.
1995: Moll U M; Ostermeyer A G; Ahomadegbe J C; Mathieu M C; Riou G
p53 mediated tumor cell response to chemotherapeutic DNA damage: a preliminary study in matched pairs of breast cancer biopsies.
Human pathology 1995;26(12):1293-301.
1995: Moll U M; LaQuaglia M; Bénard J; Riou G
Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(10):4407-11.
1995: Fajac A; Benard J; Lhomme C; Rey A; Duvillard P; Rochard F; Bernaudin J F; Riou G
c-erbB2 gene amplification and protein expression in ovarian epithelial tumors: evaluation of their respective prognostic significance by multivariate analysis.
International journal of cancer. Journal international du cancer 1995;64(2):146-51.
1995: Riou G; Barrois M; Prost S; Terrier M J; Theodore C; Levine A J
The p53 and mdm-2 genes in human testicular germ-cell tumors.
Molecular carcinogenesis 1995;12(3):124-31.
1995: Ahomadegbe J C; Barrois M; Fogel S; Le Bihan M L; Douc-Rasy S; Duvillard P; Armand J P; Riou G
High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions.
Oncogene 1995;10(6):1217-27.
1994: Prost S; Lê M G; Douc-Rasy S; Ahomadegbe J C; Spielmann M; Guérin M; Riou G
Association of c-erbB2-gene amplification with poor prognosis in non-inflammatory breast carcinomas but not in carcinomas of the inflammatory type.
International journal of cancer. Journal international du cancer 1994;58(6):763-8.
1994: Prost S; Riou G
A human small cell lung carcinoma cell line, resistant to 4'-(9-acridinylamino)-methanesulfon-m-anisidide and cross-resistant to camptothecin with a high level of topoisomerase I.
Biochemical pharmacology 1994;48(5):975-84.
1994: Ferrandis E; Da Silva J; Riou G; Bénard I
Coactivation of the MDR1 and MYCN genes in human neuroblastoma cells during the metastatic process in the nude mouse.
Cancer research 1994;54(8):2256-61.
1994: Bénard J; Bourhis J; de Vathaire F; Ferrandis E; Terrier-Lacombe M J; Lemerle J; Riou G; Hartmann O
Prognostic value of MDR1 gene expression in neuroblastoma: results of a multivariate analysis.
Progress in clinical and biological research 1994;385():111-6.
1993: Riou G; Lê M G; Travagli J P; Levine A J; Moll U M
Poor prognosis of p53 gene mutation and nuclear overexpression of p53 protein in inflammatory breast carcinoma.
Journal of the National Cancer Institute 1993;85(21):1765-7.
1993: Riou J F; Gabillot M; Riou G
Analysis of topoisomerase II-mediated DNA cleavage of the c-myc gene during HL60 differentiation.
FEBS letters 1993;334(3):369-72.
1993: Madelaine I; Prost S; Naudin A; Riou G; Lavelle F; Riou J F
Sequential modifications of topoisomerase I activity in a camptothecin-resistant cell line established by progressive adaptation.
Biochemical pharmacology 1993;45(2):339-48.
1992: Riou G; Lê M G; Favre M; Jeannel D; Bourhis J; Orth G
Human papillomavirus-negative status and c-myc gene overexpression: independent prognostic indicators of distant metastasis for early-stage invasive cervical cancers.
Journal of the National Cancer Institute 1992;84(19):1525-6.
1992: Moll U M; Riou G; Levine A J
Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(15):7262-6.
1991: Bourhis J; Dominici C; McDowell H; Raschella G; Wilson G; Castello M A; Plouvier E; Lemerle J; Riou G; Bénard J
N-myc genomic content and DNA ploidy in stage IVS neuroblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(8):1371-5.
1991: Lefevre D; Riou J F; Ahomadegbe J C; Zhou D Y; Benard J; Riou G
Study of molecular markers of resistance to m-AMSA in a human breast cancer cell line. Decrease of topoisomerase II and increase of both topoisomerase I and acidic glutathione S transferase.
Biochemical pharmacology 1991;41(12):1967-79.
1991: Riou G; Barrois M; Zhou D
Expression of anionic glutathione S transferase (GST pi) gene in carcinomas of the uterine cervix and in normal cervices.
British journal of cancer 1991;63(2):191-4.
1991: Bénard J; Bourhis J; Riou G
[Activation of N-myc oncogene and associated genes to chemoresistance, prognostic value for neuroblastoma]
Bulletin du cancer 1991;78(1):91-7.
1991: Bourhis J; De Vathaire F; Wilson G D; Hartmann O; Terrier-Lacombe M J; Boccon-Gibod L; McNally N J; Lemerle J; Riou G; Bénard J
Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma.
Cancer research 1991;51(1):33-6.
1991: Bourhis J; Hartmann O; DeVathaire F; Terrier-Lacombe M J; Boccon-Gibod L; Lemerle J; Riou G; Bénard J
Expression of MDR1 and GST pi genes in 35 advanced neuroblastomas.
Progress in clinical and biological research 1991;366():127-34.
1991: Bourhis J; Bénard J; DeVathaire F; Wilson G D; Hartmann O; Terrier-Lacombe M J; Boccon-Gibod L; Lemerle J; Riou G
Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma.
Progress in clinical and biological research 1991;366():107-13.
1990: Bourhis J; Le M G; Barrois M; Gerbaulet A; Jeannel D; Duvillard P; Le Doussal V; Chassagne D; Riou G
Prognostic value of c-myc proto-oncogene overexpression in early invasive carcinoma of the cervix.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(11):1789-96.
1990: Riou G F; Bourhis J; Le M G
The c-myc proto-oncogene in invasive carcinomas of the uterine cervix: clinical relevance of overexpression in early stages of the cancer.
Anticancer research 1990;10(5A):1225-31.
1990: Bénard J; Bourhis J; Riou G
Clinical significance of multiple drug resistance in human cancers.
Anticancer research 1990;10(5A):1297-302.
1990: Sheng Z M; Barrois M; Klijanienko J; Micheau C; Richard J M; Riou G
Analysis of the c-Ha-ras-1 gene for deletion, mutation, amplification and expression in lymph node metastases of human head and neck carcinomas.
British journal of cancer 1990;62(3):398-404.
1990: Riou G F; Zhou D; Ahomadegbe J C; Gabillot M; Duvillard P; Lhomme C
Expression of multidrug-resistance (MDR1) gene in normal epithelia and in invasive carcinomas of the uterine cervix.
Journal of the National Cancer Institute 1990;82(18):1493-6.
1990: Riou G; Favre M; Jeannel D; Bourhis J; Le Doussal V; Orth G
Association between poor prognosis in early-stage invasive cervical carcinomas and non-detection of HPV DNA.
Lancet 1990;335(8699):1171-4.
1990: Báez A; Riou J F; Le Pecq J B; Riou G
Interaction of DNA intercalator 3-nitrobenzothiazolo (3,2-a)quinolinium with DNA topoisomerases: a possible-mechanism for its biological activity.
Molecular pharmacology 1990;37(3):377-82.
1990: Riou G
[Molecular genetics of uterine cervical cancer: application to prognosis]
La Revue du praticien 1990;40(3):239-41.
1990: Guérin M; Sheng Z M; Andrieu N; Riou G
Strong association between c-myb and oestrogen-receptor expression in human breast cancer.
Oncogene 1990;5(1):131-5.
1990: Riou G; Sheng Z M; Zhou D; Lusinchi A; Le Doussal V; Barrois M
[c-myc and c-Ha-ras proto-oncogenes in cervical cancer: prognostic value]
Bulletin du cancer 1990;77(4):341-7.
1990: Bourhis J; Riou G; Bénard J
[Expression of P-glycoprotein 170 (GP 170) and drug resistance in human cancers]
Bulletin du cancer 1990;77(10):957-65.
1989: Bourhis J; Hartmann O; Benard J; Kalifa C; Riou G
Relapse from a stage IV-S neuroblastoma and N-myc amplification.
European journal of cancer & clinical oncology 1989;25(11):1653-5.
1989: Riou J F; Lefevre D; Riou G
Stimulation of the topoisomerase II induced DNA cleavage sites in the c-myc protooncogene by antitumor drugs is associated with gene expression.
Biochemistry 1989;28(23):9104-10.
1989: Bourhis J; Bénard J; Hartmann O; Boccon-Gibod L; Lemerle J; Riou G
Correlation of MDR1 gene expression with chemotherapy in neuroblastoma.
Journal of the National Cancer Institute 1989;81(18):1401-5.
1989: Bourhis J; Goldstein L J; Riou G; Pastan I; Gottesman M M; Bénard J
Expression of a human multidrug resistance gene in ovarian carcinomas.
Cancer research 1989;49(18):5062-5.
1989: Multon E; Riou J F; LeFevre D; Ahomadegbe J C; Riou G
Topoisomerase II-mediated DNA cleavage activity induced by ellipticines on the human tumor cell line N417.
Biochemical pharmacology 1989;38(13):2077-86.
1989: Bénard J; Da Silva J; Teyssier J R; Riou G
Over-expression of MDR1 gene with no DNA amplification in a multiple-drug-resistant human ovarian carcinoma cell line.
International journal of cancer. Journal international du cancer 1989;43(3):471-7.
1989: Guérin M; Gabillot M; Mathieu M C; Travagli J P; Spielmann M; Andrieu N; Riou G
Structure and expression of c-erbB-2 and EGF receptor genes in inflammatory and non-inflammatory breast cancer: prognostic significance.
International journal of cancer. Journal international du cancer 1989;43(2):201-8.
1988: Benard J; Bettan-Renaud L; Gavoille A; Pico J L; Beaujean F; Lopez M; Riou G
In vitro chemical eradication of small cell lung cancer: application in autologous bone marrow transplantation.
European journal of cancer & clinical oncology 1988;24(10):1561-6.
1988: Riou G; Barrois M; Sheng Z M; Duvillard P; Lhomme C
Somatic deletions and mutations of c-Ha-ras gene in human cervical cancers.
Oncogene 1988;3(3):329-33.
1988: Sheng Z M; Guerin M; Gabillot M; Spielmann M; Riou G
c-Ha-ras-1 polymorphism in human breast carcinomas: evidence for a normal distribution of alleles.
Oncogene research 1988;2(3):245-50.
1988: Terrier P; Sheng Z M; Schlumberger M; Tubiana M; Caillou B; Travagli J P; Fragu P; Parmentier C; Riou G
Structure and expression of c-myc and c-fos proto-oncogenes in thyroid carcinomas.
British journal of cancer 1988;57(1):43-7.
1988: Guerin M; Barrois M; Riou G
[The expression of c-myb is strongly associated with the presence of estrogen and progesterone receptors in breast cancer]
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1988;307(20):855-61.
1988: Guérin M; Barrois M; Terrier M J; Spielmann M; Riou G
Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis.
Oncogene research 1988;3(1):21-31.
1988: Riou G F
Proto-oncogenes and prognosis in early carcinoma of the uterine cervix.
Cancer surveys 1988;7(3):441-56.
1988: Douc-Rasy S; Riou J F; Ahomadegbe J C; Riou G
ATP-independent DNA topoisomerase II as potential drug target in trypanosomes.
Biology of the cell / under the auspices of the European Cell Biology Organization 1988;64(2):145-56.
1987: Vilarem M J; Riou J F; Riou G; Larsen C J
[Study, at the gene level, of the activation of topoisomerase II by antitumor agents]
Pathologie-biologie 1987;35(9):1263-9.
1987: Riou G; Barrois M; Lê M G; George M; Le Doussal V; Haie C
C-myc proto-oncogene expression and prognosis in early carcinoma of the uterine cervix.
Lancet 1987;1(8536):761-3.
1987: Riou J F; Vilarem M J; Larsen C J; Multon E; Riou G F
In vivo and in vitro stimulation by antitumor drugs of the topoisomerase II-induced cleavage sites in c-myc proto-oncogene.
NCI monographs : a publication of the National Cancer Institute 1987;(4):41-7.
1986: Riou J F; Vilarem M J; Larsen C J; Riou G
Characterization of the topoisomerase II-induced cleavage sites in the c-myc proto-oncogene. In vitro stimulation by the antitumoral intercalating drug mAMSA.
Biochemical pharmacology 1986;35(24):4409-13.
1986: Douc-Rasy S; Kayser A; Riou J F; Riou G
ATP-independent type II topoisomerase from trypanosomes.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(19):7152-6.
1986: Riou J F; Multon E; Vilarem M J; Larsen C J; Riou G
In vivo stimulation by antitumor drugs of the topoisomerase II induced cleavage sites in c-myc protooncogene.
Biochemical and biophysical research communications 1986;137(1):154-60.
1986: Riou G; Douc-Rasy S; Kayser A
Inhibitors of trypanosome topoisomerases.
Biochemical Society transactions 1986;14(2):496-9.
1986: Riou J F; Gabillot M; Philippe M; Schrevel J; Riou G
Purification and characterization of Plasmodium berghei DNA topoisomerases I and II: drug action, inhibition of decatenation and relaxation, and stimulation of DNA cleavage.
Biochemistry 1986;25(7):1471-9.
1986: Douc-Rasy S; Riou J F; Kayser A; Riou G
[A DNA topoisomerase from trypanosomes able to catenate, decatenate and unknot DNA without ATP]
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1986;302(8):283-6.
1985: Bénard J; Da Silva J; De Blois M C; Boyer P; Duvillard P; Chiric E; Riou G
Characterization of a human ovarian adenocarcinoma line, IGROV1, in tissue culture and in nude mice.
Cancer research 1985;45(10):4970-9.
1985: Riou G F; Gabillot M; Barrois M; Breitburd F; Orth G
A type-II DNA topoisomerase and a catenating protein from the transplantable VX2 carcinoma.
European journal of biochemistry / FEBS 1985;146(3):483-8.
1985: Douc-Rasy S; Terrier P; Kemeny J L; Amouroux J; Riou G
[Amplification of the expression of the c-myc oncogene in bronchial epidermoid carcinoma in man]
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1985;301(13):621-6.
1984: Douc-Rasy S; Kayser A; Riou G F
Inhibition of the reactions catalysed by a type I topoisomerase and catenating enzyme of Trypanosoma cruzi by DNA-intercalating drugs. Preferential inhibition of the catenating reaction.
The EMBO journal 1984;3(1):11-6.
1984: Riou G; Barrois M; Tordjman I; Dutronquay V; Orth G
[Presence of papillomavirus genomes and amplification of the c-myc and C-Ha-ras oncogenes in invasive cancers of the uterine cervix]
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1984;299(14):575-80.
1983: Douc-Rasy S; Kayser A; Riou G
A specific inhibitor of type I DNA-topoisomerase of Trypanosoma cruzi: dimethyl-hydroxy-ellipticinium.
Biochemical and biophysical research communications 1983;117(1):1-5.
1983: Riou G F; Gabillot M; Douc-Rasy S; Kayser A; Barrois M
A type I DNA topoisomerase from Trypanosoma cruzi.
European journal of biochemistry / FEBS 1983;134(3):479-84.
1983: Benard J; Da Silva J; Riou G
Culture of clonogenic cells from various human tumors: drug sensitivity assay.
European journal of cancer & clinical oncology 1983;19(1):65-72.
1983: Douc-Rasy S; Multon E; Kayser A; Riou G
[Inhibition by ellipticine derivatives of the reactions catalysed by the topoisomerases: preferential inhibition of topoisomerase II]
Comptes rendus des séances de l'Académie des sciences. Série III, Sciences de la vie 1983;296(19):899-904.
1982: Kayser A; Douc-Rasy S; Riou G
Decatenation of the kinetoplast DNA network of trypanosomes by a bacterial DNA-gyrase.
Biochimie 1982;64(4):285-8.
1982: Riou G; Gabillot M; Douc-Rasy S; Kayser A
[Partial purification and characterization of nuclear DNA-topoisomerases from trypanosomes (author's transl)]
Comptes rendus des séances de l'Académie des sciences. Série III, Sciences de la vie 1982;294(11):439-42.
1981: Riou G; Barrois M
The kinetoplast of DNA of Trypanosoma gambiense: comparison with the kDNA of Trypanosoma equiperdum.
Biochimie 1981;63(10):755-65.
1981: Saucier J M; Benard J; da Silva J; Riou G
Occurrence of a kinetoplast DNA-protein complex in Trypanosoma cruzi.
Biochemical and biophysical research communications 1981;101(3):988-94.
1981: Barrois M; Riou G; Galibert F
Complete nucleotide sequence of minicircle kinetoplast DNA from Trypanosoma equiperdum.
Proceedings of the National Academy of Sciences of the United States of America 1981;78(6):3323-7.
1980: Riou G; Benard J
Berenil induces the complete loss of kinetoblast DNA sequences in Trypanosoma equiperdum.
Biochemical and biophysical research communications 1980;96(1):350-4.
1980: Riou G; Baltz T; Gabillot M; Pautrizel R
Absence of kinetoplast DNA in a late antigenic variant of Trypanosoma equiperdum.
Molecular and biochemical parasitology 1980;1(2):97-105.

Sign-in to see more